Lund Model Proposes Parallel University-Hospital-Industry Track to Bridge Cell Therapy Gap
Cell and gene therapies often fail to reach patients not because the science is wrong but because academic development, hospital production capacity, regulatory planning, and commercial viability are addressed sequentially rather than simultaneously. Researchers at Lund University and Skane University Hospital have published a new collaborative model in Molecular Therapy, Methods and Clinical Development to close that translational gap.